TM-1（Cat No.:I037356）is a novel small-molecule compound with potential therapeutic applications in cancer treatment. It has shown promise in preclinical studies as a potent inhibitor of key signaling pathways involved in tumor cell growth, survival, and metastasis. TM-1 specifically targets certain kinases and transcription factors that are critical for cancer cell proliferation and resistance to apoptosis. By inhibiting these pathways, TM-1 disrupts tumor progression and enhances the effectiveness of other treatments. Ongoing research aims to evaluate its safety, efficacy, and potential in clinical trials, particularly for cancers with poor prognosis.